Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Pronto Laborinho, Ana Catarina ^a   Pinto, Susana ^a   De Carvalho, Mamede ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTIDEPRESSANT AGENT; CYTOKINE; ERYTHROPOIETIN; GROWTH FACTOR; HEPARIN; NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; OXYGEN; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; RECOMBINANT VASCULOTROPIN B; TESTOSTERONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E; VASCULOTROPIN F; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; VON HIPPEL LINDAU PROTEIN; NEUROPROTECTIVE AGENT; RILUZOLE; VEGFB PROTEIN, HUMAN;

AMYOTROPHIC LATERAL SCLEROSIS; ANGIOGENESIS; CELL HYPOXIA; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CEREBROSPINAL FLUID; CHEMOTAXIS; CHROMOSOMAL LOCALIZATION; DEGENERATIVE DISEASE; EXCITOTOXICITY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MITOSIS; MOLECULAR BIOLOGY; NERVE REGENERATION; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; OXYGEN TENSION; PLASMA; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SERUM; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM; ZEBRA FISH; ANIMAL; BRAIN STEM; CELL MOTION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; MOTOR CORTEX; NERVE FIBER; PATHOLOGY; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; BRAIN STEM; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HUMANS; MOTOR CORTEX; NEUROPROTECTIVE AGENTS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RILUZOLE; SPINAL CORD; VASCULAR ENDOTHELIAL GROWTH FACTOR B;

EID: 84901312256     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/947513     Document Type: Review

References (298)

1. Morrison K. E., Harding A. E., Disorders of the motor neurone. Bailliere's Clinical Neurology 1994 3 2 431 445 2-s2.0-0027941556 (Pubitemid 24260200)
2. Pasinelli P., Brown R. H., Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience 2006 7 9 710 723 2-s2.0-33747605320 10.1038/nrn1971 (Pubitemid 44267495)
3. Wang Y., Xiao O. M., Xie L., Banwait S., Marti H. H., Greenberg D. A., Jin K., Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. Journal of Neuroscience 2007 27 2 304 307 2-s2.0-33846221802 10.1523/JNEUROSCI.4433-06.2007 (Pubitemid 46106003)
4. Bruijn L. I., Miller T. M., Cleveland D. W., Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual Review of Neuroscience 2004 27 723 749 2-s2.0-3943102116 10.1146/annurev.neuro.27.070203.144244 (Pubitemid 39050419)
5. Wijesekera L. C., Leigh P. N., Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases 2009 4 1, article 3 2-s2.0-62749193868 10.1186/1750-1172-4-3
6. Costa J., Gomes C., de Carvalho M., Diagnosis, pathogenesis and therapeutic targets in amyotrophic lateral sclerosis. CNS and Neurological Disorders-Drug Targets 2010 9 6 764 778 2-s2.0-78649274827
7. Ferraiuolo L., Kirby J., Grierson A. J., Sendtner M., Shaw P. J., Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nature Reviews Neurology 2011 7 11 616 630 2-s2.0-80755163102 10.1038/nrneurol.2011.152
8. Cleveland D. W., Rothstein J. D., From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience 2001 2 11 806 819 2-s2.0-0035516124 10.1038/35097565 (Pubitemid 33674062)
9. Robberecht W., Philips T., The changing scene of amyotrophic lateral sclerosis. Nature Reviews Neuroscience 2013 14 4 248 264
10. Daroff R., Fenichel G., Jankovic J., Mazziotta J., Disorders of upper and lower motor neurons. Bradley's Neurology in Clinical Practice 2012 6th Chapter 72 1855 1889
11. Bendotti C., Marino M., Cheroni C., Fontana E., Crippa V., Poletti A., De Biasi S., Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: implication for protein aggregation and immune response. Progress in Neurobiology 2012 97 2 101 126 2-s2.0-80155148699 10.1016/j.pneurobio.2011.10.001
12. Turner M. R., Hardiman O., Benatar M., Brooks B. R., Chio A., de Carvalho M., Ince P. G., Lin C., Miller R. G., Mitsumoto H., Controversies and priorities in amyotrophic lateral sclerosis. The Lancet Neurology 2013 12 3 310 322
13. Nalini A., Thennarasu K., Gourie-Devi M., Shenoy S., Kulshreshtha D., Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. Journal of the Neurological Sciences 2008 272 1-2 60 70 2-s2.0-48349148074 10.1016/j.jns.2008. 04.034
14. Daroff R., Fenichel G., Jankovic J., Mazziotta J., Disorders of upper and lower motor neurons. Bradley's Neurology in Clinical Practice 2012 6th Chapter 72 1855 1889
15. Hardiman O., Van Den Berg L. H., Kiernan M. C., Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology 2011 7 11 639 649 2-s2.0-80755128213 10.1038/nrneurol.2011.153
16. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993 362 6415 59 62 2-s2.0-0027401203 10.1038/362059a0 (Pubitemid 23087289)
17. Andersen P. M., Al-Chalabi A., Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nature Reviews Neurology 2011 7 11 603 615 2-s2.0-80755133370 10.1038/nrneurol.2011.150
18. Hadano S., Hand C. K., Osuga H., Yanagisawa Y., Otomo A., Devon R. S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D. A., Kwiatkowski T., Hosler B. A., Sagie T., Skaug J., Nasir J., Brown R.H. J., Scherer S. W., Rouleau G. A., Hayden M. R., Ikeda J.-E., A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nature Genetics 2001 29 166 173 2-s2.0-17944362340 (Pubitemid 32952653)
19. Yang Y., Hentati A., Deng H.-X., Dabbagh O., Sasaki T., Hirano M., Hung W.-Y., Ouahchi K., Yan J., Azim A. C., Cole N., Gascon G., Yagmour A., Ben-Hamida M., Pericak-Vance M., Hentati F., Siddique T., The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nature Genetics 2001 29 2 160 165 2-s2.0-0035180002 (Pubitemid 32952652)
20. Chen Y.-Z., Bennett C. L., Huynh H. M., Blair I. P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M. L., Rabin B. A., Nicholson G. A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J. W., Fischbeck K. H., Timmerman V., Cornblath D. R., Chance P. F., DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). American Journal of Human Genetics 2004 74 6 1128 1135 2-s2.0-2442658908 10.1086/421054 (Pubitemid 38669312)
21. Nishimura A. L., Mitne-Neto M., Silva H. C. A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J. R. M., Gillingwater T., Webb J., Skehel P., Zatz M., A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. American Journal of Human Genetics 2004 75 5 822 831 2-s2.0-6344257200 10.1086/425287 (Pubitemid 39390489)
22. Greenway M. J., Alexander M. D., Ennis S., Traynor B. J., Corr B., Frost E., Green A., Hardiman O., A novel candidate region for ALS on chromosome 14q11.2. Neurology 2004 63 10 1936 1938 2-s2.0-8844263662 (Pubitemid 39532395)
23. Greenway M. J., Andersen P. M., Russ G., Ennis S., Cashman S., Donaghy C., Patterson V., Swingler R., Kieran D., Prehn J., Morrison K. E., Green A., Acharya K. R., Brown R. H. Jr., Hardiman O., ANG mutations segregate with familial and "sporadic" amyotrophic lateral sclerosis. Nature Genetics 2006 38 4 411 413 2-s2.0-33645422711 10.1038/ng1742
24. Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M., McCluskey L. F., Miller B. L., Masliah E., Mackenzie I. R., Feldman H., Feiden W., Kretzschmar H. A., Trojanowski J. Q., Lee V. M.-Y., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006 314 5796 130 133 2-s2.0-33749632259 10.1126/science.1134108 (Pubitemid 44547757)
25. Vance C., Rogelj B., Hortobágyi T., De Vos K. J., Nishimura A. L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K. L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P. N., Blair I. P., Nicholson G., De Belleroche J., Gallo J.-M., Miller C. C., Shaw C. E., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009 323 5918 1208 1211 2-s2.0-61349162349 10.1126/science. 1165942
26. Kwiatkowski T. J. Jr., Bosco D. A., LeClerc A. L., Tamrazian E., Vanderburg C. R., Russ C., Davis A., Gilchrist J., Kasarskis E. J., Munsat T., Valdmanis P., Rouleau G. A., Hosler B. A., Cortelli P., De Jong P. J., Yoshinaga Y., Haines J. L., Pericak-Vance M. A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P. C., Horvitz H. R., Landers J. E., Brown R. H. Jr., Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009 323 5918 1205 1208 2-s2.0-61349156118 10.1126/science.1166066
27. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H., Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010 465 7295 223 226 2-s2.0-77952419246 10.1038/nature08971
28. Orr H. T., FTD and ALS: genetic ties that bind. Neuron 2011 72 2 189 190 2-s2.0-80054842185 10.1016/j.neuron.2011.10.001
29. DeJesus-Hernandez M., Mackenzie I. R., Boeve B. F., Boxer A. L., Baker M., Rutherford N. J., Nicholson A. M., Finch N. A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.-Y. R., Karydas A., Seeley W. W., Josephs K. A., Coppola G., Geschwind D. H., Wszolek Z. K., Feldman H., Knopman D. S., Petersen R. C., Miller B. L., Dickson D. W., Boylan K. B., Graff-Radford N. R., Rademakers R., Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011 72 2 245 256 2-s2.0-80054832080 10.1016/j.neuron.2011.09.011
30. Renton A. E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J. R., Schymick J. C., Laaksovirta H., van Swieten J. C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A. M., Kaganovich A., Scholz S. W., Duckworth J., Ding J., Harmer D. W., Hernandez D. G., Johnson J. O., Mok K., Ryten M., Trabzuni D., Guerreiro R. J., Orrell R. W., Neal J., Murray A., Pearson J., Jansen I. E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J. B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M. A., Peuralinna T., Jansson L., Isoviita V.-M., Kaivorinne A.-L., Hölttä-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chiò A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J. D., Sendtner M., Drepper C., Eichler E. E., Alkan C., Abdullaev Z., Pack S. D., Dutra A., Pak E., Hardy J., Singleton A., Williams N. M., Heutink P., Pickering-Brown S., Morris H. R., Tienari P. J., Traynor B. J., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011 72 2 257 268 2-s2.0-80054837386 10.1016/j.neuron.2011.09.010
31. Ingre C., Pinto S., Birve A., Press R., Danielsson O., de Carvalho M., Gumundsson G., Andersen P. M., No association between VAPB mutations and familial or sporadic ALS in Sweden, Portugal and Iceland. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2013 14 620 627
32. van Blitterswijk M., van Es M. A., Hennekam E. A., Dooijes D., van Rheenen W., Medic J., Bourque P. R., Schelhaas H. J., van der Kooi A. J., de Visser M., Evidence for a polygenic basis of amyotrophic lateral sclerosis. Complexity of Familial Amyotrophic Lateral Sclerosis 2012 135
33. Andrews J., Amyotrophic lateral sclerosis: clinical management and research update. Current Neurology and Neuroscience Reports 2009 9 1 59 68 2-s2.0-59149099915 10.1007/s11910-009-0010-0
34. Miller R. G., Mitchell J. D., Lyon M., Moore D. H., Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews 2007 1 CD001447 2-s2.0-34247887576
35. de Carvalho M., Costa J., Swash M., Clinical trials in ALS: a review of the role of clinical and neurophysiological measurements. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2005 6 1 202 212 2-s2.0-29244435765 10.1080/14660820510011997
36. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Dorpe J. V., Hellings P., Gorselink M., Heymans S., Theilmeier G., Dewerchin M., Laudenbach V., Vermylen P., Raat H., Acker T., Vleminckx V., Bosch L. V. D., Cashman N., Fujisawa H., Drost M. R., Sciot R., Bruyninckx F., Hicklin D. J., Ince C., Gressens P., Lupu F., Plate K. H., Robberecht W., Herbert J.-M., Collen D., Carmeliet P., Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nature Genetics 2001 28 2 131 138 2-s2.0-0034978562 10.1038/88842 (Pubitemid 32538057)
37. Jin K. L., Mao X. O., Greenberg D. A., Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proceedings of the National Academy of Sciences of the United States of America 2000 97 18 10242 10247 2-s2.0-0000481740
38. Jin K. L., Mao X. O., Nagayama T., Goldsmith P. C., Greenberg D. A., Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3'-kinase/Akt signaling by global cerebral ischemia in the rat. Neuroscience 2000 100 4 713 717 2-s2.0-0034638448 10.1016/S0306-4522(00) 00331-6
39. Silverman W. F., Krum J. M., Mani N., Rosenstein J. M., Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 1999 90 4 1529 1541 2-s2.0-0032903416 10.1016/S0306-4522(98)00540-5 (Pubitemid 29170166)
40. Lambrechts D., Storkebaum E., Morimoto M., Del-Favero J., Desmet F., Marklund S. L., Wyns S., Thijs V., Andersson J., Van Marion I., Al-Chalabi A., Bornes S., Musson R., Hansen V., Beckman L., Adolfsson R., Pall H. S., Prats H., Vermeire S., Rutgeerts P., Katayama S., Awata T., Leigh N., Lang-Lazdunski L., Dewerchin M., Shaw C., Moons L., Vlietinck R., Morrison K. E., Robberecht W., Van Broeckhoven C., Collen D., Andersen P. M., Carmeliet P., VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nature Genetics 2003 34 4 383 394 2-s2.0-0041903805 10.1038/ng1211 (Pubitemid 36935331)
41. Azzouz M., Ralph G. S., Storkebaum E., Walmsley L. E., Mitrophanous K. A., Kingsman S. M., Carmellet P., Mazarakis N. D., VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004 429 6990 413 417 2-s2.0-2642526164 10.1038/nature02544 (Pubitemid 38715132)
42. Storkebaum E., Carmeliet P., VEGF: a critical player in neurodegeneration. Journal of Clinical Investigation 2004 113 1 14 18 2-s2.0-1542571389 10.1172/JCI200420682 (Pubitemid 38541624)
43. Storkebaum E., Lambrechts D., Carmeliet P., VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays 2004 26 9 943 954 2-s2.0-4644234505 10.1002/bies.20092 (Pubitemid 39273068)
44. Leung D. W., Cachianes G., Kuang W.-J., Goeddel D. V., Ferrara N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989 246 4935 1306 1309 2-s2.0-0024818355 (Pubitemid 20066716)
45. Ferrara N., Vascular endothelial growth factor as a target for anticancer therapy. Oncologist 2004 9 1 2 10 2-s2.0-2942590261 10.1634/theoncologist.9- suppl-1-2 (Pubitemid 38747842)
46. Ferrara N., Vascular endothelial growth factor: basic science and clinical progress. Endocrine Reviews 2004 25 4 581 611 2-s2.0-4143136640 10.1210/er.2003-0027 (Pubitemid 39099316)
47. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M., Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 1995 146 5 1029 1039 2-s2.0-0029004025
48. Ruhrberg C., Growing and shaping the vascular tree: multiple roles for VEGF. BioEssays 2003 25 11 1052 1060 2-s2.0-0242636164 10.1002/bies.10351 (Pubitemid 37411765)
49. Takahashi H., Shibuya M., The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clinical Science 2005 109 3 227 241 2-s2.0-25144511910 10.1042/CS20040370 (Pubitemid 41337127)
50. Hoeben A., Landuyt B., Highley M. S., Wildiers H., Van Oosterom A. T., De Bruijn E. A., Vascular endothelial growth factor and angiogenesis. Pharmacological Reviews 2004 56 4 549 580 2-s2.0-10644279947 10.1124/pr.56.4.3 (Pubitemid 39658463)
51. Vincenti V., Cassano C., Rocchi M., Persico M. G., Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996 93 8 1493 1495 2-s2.0-0029868465 (Pubitemid 26115412)
52. Ferrara N., Gerber H.-P., LeCouter J., The biology of VEGF and its receptors. Nature Medicine 2003 9 6 669 676 2-s2.0-0037699954 10.1038/nm0603-669 (Pubitemid 36749215)
53. Olsson A.-K., Dimberg A., Kreuger J., Claesson-Welsh L., VEGF receptor signalling-in control of vascular function. Nature Reviews Molecular Cell Biology 2006 7 5 359 371 2-s2.0-33646107369 10.1038/nrm1911
54. Houck K. A., Ferrara N., Winer J., Cachianes G., Li B., Leung D. W., The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Molecular Endocrinology 1991 5 12 1806 1814 2-s2.0-0026395163
55. Bogaert E., Van Damme P., Van Den Bosch L., Robberecht W., Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle and Nerve 2006 34 4 391 405 2-s2.0-33749385489 10.1002/mus.20609 (Pubitemid 44506706)
56. Roskoski R. Jr., Vascular endothelial growth factor (VEGF) signaling in tumor progression. Critical Reviews in Oncology/Hematology 2007 62 3 179 213 2-s2.0-33947370773 10.1016/j.critrevonc.2007.01.006 (Pubitemid 46679285)
57. Biselli-Chicote P. M., Oliveira A. R., Pavarino E. C., Goloni-Bertollo E. M., VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer. Journal of Cancer Research and Clinical Oncology 2012 138 3 363 370 2-s2.0-84859717742 10.1007/s00432-011-1073-2
58. Falk T., Gonzalez R. T., Sherman S. J., The Yin and Yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's disease. International Journal of Molecular Sciences 2010 11 8 2875 2900 2-s2.0-77957928091 10.3390/ijms11082875
59. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M. G., Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proceedings of the National Academy of Sciences of the United States of America 1991 88 20 9267 9271 2-s2.0-0026052391 (Pubitemid 21915612)
60. Persico M., Vincenti V., DiPalma T., Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Vascular Growth Factors and Angiogenesis 1999 Springer 31 40 Current Topics in Microbiology and Immunology (Pubitemid 128767693)
61. Autiero M., Waltenberger J., Communi D., Kranz A., Moons L., Lambrechts D., Kroll J., Plaisance S., De Mol M., Bono F., Kliche S., Fellbrich G., Ballmer-Hofer K., Maglione D., Mayr-Beyrle U., Dewerchin M., Dombrowski S., Stanimirovic D., Van Hummelen P., Dehio C., Hicklin D. J., Persico G., Herbert J.-M., Communi D., Shibuya M., Collen D., Conway E. M., Carmeliet P., Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nature Medicine 2003 9 7 936 943 2-s2.0-0037703184 10.1038/nm884 (Pubitemid 36889938)
62. Park J. E., Chen H. H., Winer J., Houck K. A., Ferrara N., Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Journal of Biological Chemistry 1994 269 41 25646 25654 2-s2.0-0028134936
63. Roy H., Bhardwaj S., Ylä-Herttuala S., Biology of vascular endothelial growth factors. FEBS Letters 2006 580 12 2879 2887 2-s2.0-33646569993 10.1016/j.febslet.2006.03.087 (Pubitemid 43729175)
64. De Falco S., Gigante B., Persico M. G., Structure and function of placental growth factor. Trends in Cardiovascular Medicine 2002 12 6 241 246 2-s2.0-0036701874 10.1016/S1050-1738(02)00168-8 (Pubitemid 35286760)
65. Ferrara N., Davis-Smyth T., The biology of vascular endothelial growth factor. Endocrine Reviews 1997 18 1 4 25 2-s2.0-0031039243 10.1210/er.18.1.4 (Pubitemid 27076453)
66. Grimmond S., Lagercrantz J., Drinkwater C., Silins G., Townson S., Pollock P., Gotley D., Carson E., Rakar S., Nordenskjöld M., Ward L., Hayward N., Weber G., Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Research 1996 6 2 124 131 2-s2.0-19144366076 (Pubitemid 26111339)
67. Paavonen K., Horelli-Kuitunen N., Chilov D., Kukk E., Pennanen S., Kallioniemi O.-P., Pajusola K., Olofsson B., Eriksson U., Joukov V., Palotie A., Alitalo K., Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 1996 93 6 1079 1082 2-s2.0-9044222479 (Pubitemid 26089805)
68. Salven P., Lymboussaki A., Heikkilä P., Jääskela-Saari H., Enholm B., Aase K., Von Euler G., Eriksson U., Alitalo K., Joensuu H., Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. American Journal of Pathology 1998 153 1 103 108 2-s2.0-18844471324 (Pubitemid 28317512)
69. Li X., Kumar A., Lee C., Tang Z., Li Y., Arjunan P., Hou X., Zhang F., Can VEGF-B be used to treat neurodegenerative diseases? Neurodegenerative Diseases -Processes, Prevention, Protection and Monitoring 2011
70. Tammela T., Enholm B., Alitalo K., Paavonen K., The biology of vascular endothelial growth factors. Cardiovascular Research 2005 65 3 550 563 2-s2.0-12344274486 10.1016/j.cardiores.2004.12.002 (Pubitemid 40138976)
71. Enholm B., Paavonen K., Ristimäki A., Kumar V., Gunji Y., Klefstrom J., Kivinen L., Laiho M., Olofsson B., Joukov V., Eriksson U., Alitalo K., Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997 14 20 2475 2483 2-s2.0-8544249876 10.1038/sj.onc.1201090 (Pubitemid 27268166)
72. Olofsson B., Jeltsch M., Eriksson U., Alitalo K., Current biology of VEGF-B and VEGF-C. Current Opinion in Biotechnology 1999 10 6 528 538 2-s2.0-0032735698 10.1016/S0958-1669(99)00024-5
73. Li X., Tjwa M., Van Hove I., Enholm B., Neven E., Paavonen K., Jeltsch M., Juan T. D., Sievers R. E., Chorianopoulos E., Wada H., Vanwildemeersch M., Noel A., Foidart J.-M., Springer M. L., Von Degenfeld G., Dewerchin M., Blau H. M., Alitalo K., Eriksson U., Carmeliet P., Moons L., Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1614 1620 2-s2.0-51649123294 10.1161/ATVBAHA.107.158725
74. Aase K., Lymboussaki A., Kaipainen A., Olofsson B., Alitalo K., Eriksson U., Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature. Developmental Dynamics 1999 215 1 12 25 (Pubitemid 29215700)
75. Yamada Y., Nezu J.-I., Shimane M., Hirata Y., Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 1997 42 3 483 488 2-s2.0-0031570672 10.1006/geno.1997.4774 (Pubitemid 27287391)
76. Oh S.-J., Jeltsch M. M., Birkenhäger R., McCarthy J. E. G., Weich H. A., Christ B., Alitalo K., Wilting J., VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Developmental Biology 1997 188 1 96 109 2-s2.0-0031213636 10.1006/dbio.1997.8639 (Pubitemid 27360090)
77. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., Swartz M., Fukumura D., Jain R. K., Alitalo K., Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997 276 5317 1423 1425 2-s2.0-0030973506 10.1126/science.276.5317.1423 (Pubitemid 27235412)
78. Rissanen T. T., Markkanen J. E., Gruchala M., Heikura T., Puranen A., Kettunen M. I., Kholová I., Kauppinen R. A., Achen M. G., Stacker S. A., Alitalo K., Ylä-Herttuala S., VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circulation Research 2003 92 10 1098 1106 2-s2.0-0037714018 10.1161/01.RES.0000073584.46059.E3 (Pubitemid 36665855)
79. Achen M. G., McColl B. K., Stacker S. A., Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005 7 2 121 127 2-s2.0-13844265843 10.1016/j.ccr.2005.01.017 (Pubitemid 40248338)
80. Tammela T., Zarkada G., Wallgard E., Murtomäki A., Suchting S., Wirzenius M., Waltari M., Hellström M., Schomber T., Peltonen R., Freitas C., Duarte A., Isoniemi H., Laakkonen P., Christofori G., Ylä-Herttuala S., Shibuya M., Pytowski B., Eichmann A., Betsholtz C., Alitalo K., Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008 454 7204 656 660 2-s2.0-48349129069 10.1038/nature07083
81. Shibuya M., Vascular endothelial growth factor-dependent and-independent regulation of angiogenesis. Angiogenesis 2008 12 15
82. Achen M. G., Stacker S. A., Vascular endothelial growth factor-D: signaling mechanisms, biology, and clinical relevance. Growth Factors 2012 30 5 283 296
83. Saharinen P., Tammela T., Karkkainen M. J., Alitalo K., Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends in Immunology 2004 25 7 387 395 2-s2.0-2942668041 10.1016/j.it.2004.05.003 (Pubitemid 38780956)
84. Lohela M., Saaristo A., Veikkola T., Alitalo K., Lymphangiogenic growth factors, receptors and therapies. Thrombosis and Haemostasis 2003 90 2 167 184 2-s2.0-0041561201 (Pubitemid 36992494)
85. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO Journal 1996 15 2 290 298 2-s2.0-0030026897 (Pubitemid 26029207)
86. Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H. G., Ziche M., Lanz C., Büttner M., Rziha H.-J., Dehio C., A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO Journal 1999 18 2 363 374 2-s2.0-0033556287 10.1093/emboj/18.2.363 (Pubitemid 29041945)
87. Junqueira de Azevedo I. D. L. M., Poliselli Farsky S. H., Oliveira M. L. S., Ho P. L., Molecular cloning and expression of a functional snake venom vascular endothelium growth factor (VEGF) from the Bothrops insularis pit viper: a new member of the VEGF family of proteins. Journal of Biological Chemistry 2001 276 43 39836 39842 2-s2.0-0035955692 10.1074/jbc.M106531200
88. Ferrara N., VEGF and Its Receptors. VEGF and Cancer 2004 Chapter 1 2 11
89. Terman B. I., Carrion M. E., Kovacs E., Rasmussen B. A., Eddy R. L., Shows T. B., Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991 6 9 1677 1683 2-s2.0-0025739016 (Pubitemid 21924273)
90. De Almodovar C. R., Lambrechts D., Mazzone M., Carmeliet P., Role and therapeutic potential of VEGF in the nervous system. Physiological Reviews 2009 89 2 607 648 2-s2.0-67649973540 10.1152/physrev.00031.2008
91. Alitalo K., Carmeliet P., Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002 1 3 219 227 2-s2.0-0036527585 10.1016/S1535-6108(02)00051-X (Pubitemid 41039145)
92. Shibuya M., Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. Journal of Biochemistry and Molecular Biology 2006 39 5 469 478 2-s2.0-33750842076 (Pubitemid 44714526)
93. Satoh H., Yoshida M., Matsushime H., Regional localization of the human c-ros-1 on 6q22 and flt on 13q12. Japanese Journal of Cancer Research 1987 78 8 772 775 2-s2.0-0023186218 (Pubitemid 17130961)
94. Zachary I., Gliki G., Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovascular Research 2001 49 3 568 581 2-s2.0-0035895711 10.1016/S0008- 6363(00)00268-6 (Pubitemid 32146420)
95. Gerber H.-P., Condorelli F., Park J., Ferrara N., Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. Journal of Biological Chemistry 1997 272 38 23659 23667 2-s2.0-0030751493 10.1074/jbc.272.38.23659 (Pubitemid 27410939)
96. Kendall R. L., Thomas K. A., Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proceedings of the National Academy of Sciences of the United States of America 1993 90 22 10705 10709 2-s2.0-0027421333 10.1073/pnas.90.22.10705 (Pubitemid 23347111)
97. Levine R. J., Maynard S. E., Qian C., Lim K.-H., England L. J., Yu K. F., Schisterman E. F., Thadhani R., Sachs B. P., Epstein F. H., Sibai B. M., Sukhatme V. P., Karumanchi S. A., Circulating angiogenic factors and the risk of preeclampsia. The New England Journal of Medicine 2004 350 7 672 683 2-s2.0-10744227199 10.1056/NEJMoa031884 (Pubitemid 38364626)
98. Thadhani R., Mutter W. P., Wolf M., Levine R. J., Taylor R. N., Sukhatme V. P., Ecker J., Karumanchi S. A., First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. Journal of Clinical Endocrinology and Metabolism 2004 89 2 770 775 2-s2.0-1442303327 10.1210/jc.2003-031244 (Pubitemid 38269892)
99. Sait S. N. J., Dougher-Vermazen M., Shows T. B., Terman B. I., The kinase insert domain receptor gene (KDR) has been relocated to chromosome 4q11→q12. Cytogenetics and Cell Genetics 1995 70 1-2 145 146 2-s2.0-0028956672
100. Gille H., Kowalski J., Li B., LeCouter J., Moffat B., Zioncheck T. F., Pelletier N., Ferrara N., Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants. Journal of Biological Chemistry 2001 276 5 3222 3230 2-s2.0-0035793623 10.1074/jbc. M002016200
101. Zachary I., Vascular endothelial growth factor: how it transmits its signal. Experimental Nephrology 1998 6 6 480 487 2-s2.0-0031770547 (Pubitemid 28518369)
102. Sondell M., Lundborg G., Kanje M., Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. Journal of Neuroscience 1999 19 14 5731 5740 2-s2.0-0033565417 (Pubitemid 29327910)
103. Jin K., Zhu Y., Sun Y., Mao X. O., Xie L., Greenberg D. A., Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America 2002 99 18 11946 11950 2-s2.0-0037015059 10.1073/pnas.182296499 (Pubitemid 34994504)
104. Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X.-F., Breitman M. L., Schuh A. C., Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 1995 376 6535 62 66 2-s2.0-0029006696
105. Hiratsuka S., Minowa O., Kuno J., Noda T., Shibuya M., Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 1998 95 16 9349 9354 2-s2.0-0032482978 10.1073/pnas.95.16.9349 (Pubitemid 28506234)
106. Shibuya M., Claesson-Welsh L., Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research 2006 312 5 549 560 2-s2.0-33344474964 10.1016/j.yexcr.2005.11.012 (Pubitemid 43290332)
107. Achen M. G., Jeltsch M., Kukk E., Mäkinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A., Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proceedings of the National Academy of Sciences of the United States of America 1998 95 2 548 553 2-s2.0-0031905861 10.1073/pnas.95.2.548 (Pubitemid 28083780)
108. Pajusola K., Aprelikova O., Pelicci G., Weich H., Claesson-Welsh L., Alitalo K., Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 1994 9 12 3545 3555 2-s2.0-0028091775 (Pubitemid 24359392)
109. Cébe-Suarez S., Zehnder-Fjällman A., Ballmer-Hofer K., The role of VEGF receptors in angiogenesis; complex partnerships. Cellular and Molecular Life Sciences 2006 63 5 601 615 2-s2.0-33645056182 10.1007/s00018-005-5426-3
110. Kaipainen A., Korhonen J., Mustonen T., Van Hinsbergh V. W. M., Fang-G. H., Dumont D., Breitman M., Alitalo K., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Sciences of the United States of America 1995 92 8 3566 3570 2-s2.0-0028938746
111. Koch S., Claesson-Welsh L., Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harbor Perspectives in Medicine 2012 2 7 a006502
112. Lee J., Gray A., Yuan J., Luoh S.-M., Avraham H., Wood W. I., Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 1988 1992 2-s2.0-0029962242 10.1073/pnas.93.5.1988 (Pubitemid 26079868)
113. Le Bras B., Barallobre M.-J., Homman-Ludiye J., Ny A., Wyns S., Tammela T., Haiko P., Karkkainen M. J., Yuan L., Muriel M.-P., Chatzopoulou E., Bréant C., Zalc B., Carmeliet P., Alitalo K., Eichmann A., Thomas J.-L., VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nature Neuroscience 2006 9 3 340 348 2-s2.0-33344460695 10.1038/nn1646 (Pubitemid 43290963)
114. Hamada K., Oike Y., Takakura N., Ito Y., Jussila L., Dumont D. J., Alitalo K., Suda T., VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 2000 96 12 3793 3800 2-s2.0-0034554844
115. Dumont D. J., Jussila L., Taipale J., Lymboussaki A., Mustonen T.,
116. Klagsbrun M., Takashima S., Mamluk R., The role of neuropilin in vascular and tumor biology. Advances in Experimental Medicine and Biology 2002 515 33 48 2-s2.0-0036933684 (Pubitemid 36324180)
117. Neufeld G., Cohen T., Shraga N., Lange T., Kessler O., Herzog Y., The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends in Cardiovascular Medicine 2002 12 1 13 19 2-s2.0-0036139515 10.1016/S1050-1738(01)00140-2 (Pubitemid 34048706)
118. Neufeld G., Kessler O., Herzog Y., The interaction of neuropilin-1 and neurropilin-2 with tyrosine-kinase receptors for VEGF. Advances in Experimental Medicine and Biology 2002 515 81 90 2-s2.0-0036941610 (Pubitemid 36324184)
119. Soker S., Takashima S., Miao H. Q., Neufeld G., Klagsbrun M., Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor. Cell 1998 92 6 735 745 2-s2.0-0032549799 10.1016/S0092-8674(00)81402-6 (Pubitemid 28155313)
120. Soker S., Miao H.-Q., Nomi M., Takashima S., Klagsbrun M., VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. Journal of Cellular Biochemistry 2002 85 2 357 368 2-s2.0-0036009760 10.1002/jcb.10140 (Pubitemid 34274903)
121. Geretti E., Shimizu A., Klagsbrun M., Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 2008 11 1 31 39 2-s2.0-41049099329 10.1007/s10456-008-9097-1
122. Bagri A., Tessier-Lavigne M., Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Advances in Experimental Medicine and Biology 2002 515 13 31 2-s2.0-0036942108 (Pubitemid 36324179)
123. Kolodkin A. L., Levengood D. V., Rowe E. G., Tai Y.-T., Giger R. J., Ginty D. D., Neuropilin is a semaphorin III receptor. Cell 1997 90 4 753 762 2-s2.0-0030829388 10.1016/S0092-8674(00)80535-8 (Pubitemid 27357966)
124. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., Fujisawa H., Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995 121 12 4309 4318 2-s2.0-0029562097 (Pubitemid 26007578)
125. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H., A requirement for neuropilin-1 in embryonic vessel formation. Development 1999 126 21 4895 4902 2-s2.0-0032707249
126. Lee P., Goishi K., Davidson A. J., Mannix R., Zon L., Klagsbrun M., Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proceedings of the National Academy of Sciences of the United States of America 2002 99 16 10470 10475 2-s2.0-0036678171 10.1073/pnas.162366299
127. Yuan L., Moyon D., Pardanaud L., Bréant C., Karkkainen M. J., Alitalo K., Eichmann A., Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002 129 20 4797 4806 2-s2.0-0036803751 (Pubitemid 35282411)
128. Takashima S., Kitakaze M., Asakura M., Asanuma H., Sanada S., Tashiro F., Niwa H., Miyazaki J.-I., Hirota S., Kitamura Y., Kitsukawa T., Fujisawa H., Klagsbrun M., Hori M., Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2002 99 6 3657 3662 2-s2.0-0037133617 10.1073/pnas.022017899 (Pubitemid 34252162)
129. Xie K., Wei D., Shi Q., Huang S., Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine and Growth Factor Reviews 2004 15 5 297 324 2-s2.0-4344692045 10.1016/j.cytogfr.2004.04.003 (Pubitemid 39140697)
130. Krantz S. B., Erythropoietin. Blood 1991 77 3 419 434 2-s2.0-0026019106
131. Forsythe J. A., Jiang B.-H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L., Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 1996 16 9 4604 4613 2-s2.0-0029761644 (Pubitemid 26272112)
132. Ryan H. E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J. M., Johnson R. S., Hypoxia-inducible factor-1 α is a positive factor in solid tumor growth. Cancer Research 2000 60 15 4010 4015 2-s2.0-0033870727 (Pubitemid 30636574)
133. Maxwell P. H., Ratcliffe P. J., Oxygen sensors and angiogenesis. Seminars in Cell and Developmental Biology 2002 13 1 29 37 2-s2.0-0036446922 10.1006/scdb.2001.0287 (Pubitemid 35418312)
134. Ferrara N., Alitalo K., Clinical applications of angiogenic growth factors and their inhibitors. Nature Medicine 1999 5 12 1359 1364 2-s2.0-0032710319 10.1038/70928
135. Tsuzuki Y., Fukumura D., Oosthuyse B., Koike C., Carmeliet P., Jain R. K., Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 α → hypoxia response element → VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Research 2000 60 22 6248 6252 2-s2.0-0033693293
136. Dvorak H. F., Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 2002 20 21 4368 4380 2-s2.0-0036842215 10.1200/JCO.2002.10.088 (Pubitemid 35266299)
137. Pagès G., Pouysségur J., Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovascular Research 2005 65 3 564 573 (Pubitemid 40138977)
138. 2 tension. Proceedings of the National Academy of Sciences of the United States of America 1995 92 12 5510 5514 2-s2.0-0029051439 10.1073/pnas.92.12.5510
139. Wang G. L., Semenza G. L., Purification and characterization of hypoxia-inducible factor 1. Journal of Biological Chemistry 1995 270 3 1230 1237 2-s2.0-0028816847 10.1074/jbc.270.3.1230
140. Dachs G. U., Tozer G. M., Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. European Journal of Cancer 2000 36 13 1649 1660 2-s2.0-0033867776 10.1016/S0959-8049(00)00159-3 (Pubitemid 30616369)
141. Levy A. P., Levy N. S., Wegner S., Goldberg M. A., Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. Journal of Biological Chemistry 1995 270 22 13333 13340 2-s2.0-0029039195 10.1074/jbc.270.22.13333
142. Salceda S., Caro J., Hypoxia-inducible factor 1 α (HIF-1 α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. Journal of Biological Chemistry 1997 272 36 22642 22647 2-s2.0-0030961006 10.1074/jbc.272.36.22642 (Pubitemid 27386079)
143. Pugh C. W., Ratcliffe P. J., Regulation of angiogenesis by hypoxia: role of the HIF system. Nature Medicine 2003 9 6 677 684 2-s2.0-0038037735 10.1038/nm0603-677 (Pubitemid 36749216)
144. 2 sensing. Science 2001 292 5516 464 468 2-s2.0-0035917313 (Pubitemid 32335941)
145. Semenza G. L., HIF-1 and mechanisms of hypoxia sensing. Current Opinion in Cell Biology 2001 13 2 167 171 2-s2.0-0035313697 10.1016/S0955-0674(00)00194- 0 (Pubitemid 32209217)
146. Mole D. R., Maxwell P. H., Pugh C. W., Ratcliffe P. J., Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life 2001 52 1-2 43 47 2-s2.0-0036138398 10.1080/ 15216540252774757 (Pubitemid 33769668)
147. Sutter C. H., Laughner E., Semenza G. L., Hypoxia-inducible factor 1 α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proceedings of the National Academy of Sciences of the United States of America 2000 97 9 4748 4753 2-s2.0-0034712939 (Pubitemid 30238629)
148. Semenza G. L., Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010 29 5 625 634 2-s2.0-76349095132 10.1038/onc.2009.441
149. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z., Vascular endothelial growth factor (VEGF) and its receptors. FASEB Journal 1999 13 1 9 22 2-s2.0-0032907687 (Pubitemid 29038270)
150. Ben-Av P., Crofford L. J., Wilder R. L., Hla T., Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Letters 1995 372 1 83 87 2-s2.0-0029083832 10.1016/0014-5793(95)00956-A
151. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., Alitalo K., Vascular endothelial growth factor is induced in response to transforming growth factor- β in fibroblastic and epithelial cells. Journal of Biological Chemistry 1994 269 9 6271 6274 2-s2.0-0028221238 (Pubitemid 24190991)
152. Harada S.-I., Nagy J. A., Sullivan K. A., Thomas K. A., Endo N., Rodan G. A., Rodan S. B., Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. Journal of Clinical Investigation 1994 93 6 2490 2496 2-s2.0-0028263883 (Pubitemid 24177163)
153. Li J., Perrella M. A., Tsai J.-C., Yet S.-F., Hsieh C.-M., Yoshizumi M., Patterson C., Endege W. O., Zhou F., Lee M.-E., Induction of vascular endothelial growth factor gene expression by interleukin-1 β in rat aortic smooth muscle cells. Journal of Biological Chemistry 1995 270 1 308 312 2-s2.0-0028804682 10.1074/jbc.270.1.308
154. Cohen T., Nahari D., Cerem L. W., Neufeld G., Levin B.-Z., Interleukin 6 induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry 1996 271 2 736 741 2-s2.0-0030046481 10.1074/jbc.271.2.736 (Pubitemid 26034921)
155. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H. A., Kohno K., Kuwano M., Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells: possible roles of SP-1. Journal of Biological Chemistry 1996 271 45 28220 28228 2-s2.0-0029953517 10.1074/jbc.271.45.28220 (Pubitemid 26374633)
156. Deroanne C. F., Hajitou A., Calberg-Bacq C.-M., Nusgens B. V., Lapière C. M., Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Research 1997 57 24 5590 5597 2-s2.0-0031457364 (Pubitemid 28006769)
157. Ho Q. T., Kuo C. J., Vascular endothelial growth factor: biology and therapeutic applications. International Journal of Biochemistry and Cell Biology 2007 39 7-8 1349 1357 2-s2.0-34447108810 10.1016/j.biocel.2007.04.010 (Pubitemid 47031045)
158. Frank S., Hubner G., Breier G., Longaker M. T., Greenhalgh D. G., Werner S., Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. Journal of Biological Chemistry 1995 270 21 12607 12613 2-s2.0-0029045246 10.1074/jbc.270.21.12607
159. Finkenzeller G., Sparacio A., Technau A., Marmé D., Siemeister G., Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 1997 15 6 669 676 2-s2.0-0030753430 (Pubitemid 27389929)
160. Loureiro R. M. B., D'Amore P. A., Transcriptional regulation of vascular endothelial growth factor in cancer. Cytokine and Growth Factor Reviews 2005 16 1 77 89 2-s2.0-14044271973 10.1016/j.cytogfr.2005.01.005 (Pubitemid 40279118)
161. Grugel S., Finkenzeller G., Weindel K., Barleon B., Marme D., Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. Journal of Biological Chemistry 1995 270 43 25915 25919 2-s2.0-0028834638 10.1074/jbc.270.43.25915
162. Siemeister G., Weindel K., Mohrs K., Barleon B., Martiny-Baron G., Marmé D., Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Research 1996 56 10 2299 2301 2-s2.0-0029920054 (Pubitemid 26154077)
163. Iliopoulos O., Levy A. P., Jiang C., Kaelin W. G. Jr., Goldberg M. A., Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proceedings of the National Academy of Sciences of the United States of America 1996 93 20 10595 10599 2-s2.0-0029785321 10.1073/pnas.93.20.10595 (Pubitemid 26333032)
164. Jin K., Minami M., Lan J. Q., Mao X. O., Batteur S., Simon R. P., Greenberg D. A., Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4710 4715 2-s2.0-0035836656 10.1073/pnas.081011098 (Pubitemid 32295041)
165. Sun Y., Jin K., Childs J. T., Xie L., Mao X. O., Greenberg D. A., Increased severity of cerebral ischemic injury in vascular endothelial growth factor-B-deficient mice. Journal of Cerebral Blood Flow and Metabolism 2004 24 10 1146 1152 2-s2.0-4944253249 10.1097/01.WCB.0000134477.38980.38 (Pubitemid 39332153)
166. Sun Y., Jin K., Xie L., Childs J., Mao X. O., Logvinova A., Greenberg D. A., VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. Journal of Clinical Investigation 2003 111 12 1843 1851 2-s2.0-0041743159 10.1172/JCI200317977 (Pubitemid 38057729)
167. Mackenzie F., Ruhrberg C., Diverse roles for VEGF-A in the nervous system. Development 2012 139 8 1371 1380 2-s2.0-84858841220 10.1242/dev.072348
168. Rosenstein J. M., Krum J. M., Ruhrberg C., VEGF in the nervous system. Organogenesis 2010 6 2 107 114 2-s2.0-77953494291
169. Abrous D. N., Koehl M., Le Moal M., Adult neurogenesis: from precursors to network and physiology. Physiological Reviews 2005 85 2 523 569 2-s2.0-15544370150 10.1152/physrev.00055.2003 (Pubitemid 40404636)
170. Palmer T. D., Willhoite A. R., Gage F. H., Vascular niche for adult hippocampal neurogenesis. Journal of Comparative Neurology 2000 425 4 479 494
171. Greenberg D. A., Jin K., From angiogenesis to neuropathology. Nature 2005 438 7070 954 959 2-s2.0-30744477950 10.1038/nature04481 (Pubitemid 43093961)
172. Carmeliet P., de Almodovar C. R., VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration. Cellular and Molecular Life Sciences 2013 70 10 1763 1778
173. Louissaint A. Jr., Rao S., Leventhal C., Goldman S. A., Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 2002 34 6 945 960 2-s2.0-0037071892 10.1016/S0896-6273(02)00722-5 (Pubitemid 34722284)
174. Jung K.-H., Chu K., Lee S.-T., Kim S.-J., Sinn D.-I., Kim S. U., Kim M., Roh J.-K., Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Research 2006 1073-1074 1 190 201 2-s2.0-33644960902 10.1016/j.brainres.2005.12.037
175. Warner-Schmidt J. L., Duman R. S., VEGF as a potential target for therapeutic intervention in depression. Current Opinion in Pharmacology 2008 8 1 14 19 2-s2.0-38649096949 10.1016/j.coph.2007.10.013 (Pubitemid 351168696)
176. Warner-Schmidt J. L., Duman R. S., Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006 16 3 239 249 2-s2.0-33645109592 10.1002/hipo.20156
177. Warner-Schmidt J. L., Duman R. S., VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proceedings of the National Academy of Sciences of the United States of America 2007 104 11 4647 4652 2-s2.0-34248388548 10.1073/pnas.0610282104 (Pubitemid 47186279)
178. Cao L., Jiao X., Zuzga D. S., Liu Y., Fong D. M., Young D., During M. J., VEGF links hippocampal activity with neurogenesis, learning and memory. Nature Genetics 2004 36 8 827 835 2-s2.0-3542999278 10.1038/ng1395 (Pubitemid 39014099)
179. Sun Y., Jin K., Childs J. T., Xie L., Mao X. O., Greenberg D. A., Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Developmental Biology 2006 289 2 329 335 2-s2.0-30044451865 10.1016/j.ydbio.2005.10.016 (Pubitemid 43049936)
180. Calvo C.-F., Fontaine R. H., Soueid J., Tammela T., Makinen T., Alfaro-Cervello C., Bonnaud F., Miguez A., Benhaim L., Xu Y., Barallobre M.-J., Moutkine I., Lyytikkä J., Tatlisumak T., Pytowski B., Zalc B., Richardson W., Kessaris N., Garcia-Verdugo J. M., Alitalo K., Eichmann A., Thomas J.-L., Vascular endothelial growth factor receptor 3 directly regulates murine neurogenesis. Genes and Development 2011 25 8 831 844 2-s2.0-79955408372 10.1101/gad.615311
181. Greenberg D. A., Jin K., VEGF and ALS: the luckiest growth factor? Trends in Molecular Medicine 2004 10 1 1 3 2-s2.0-0742304302 10.1016/j.molmed.2003.11. 006 (Pubitemid 38156191)
182. Kun Lin Jin K. L. J., Xiao Ou Mao X. O. M., Greenberg D. A., Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal. Journal of Molecular Neuroscience 2000 14 3 197 203 2-s2.0-0033848792 (Pubitemid 30660810)
183. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M. P., Mitsuda N., Tohyama M., Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. The FASEB Journal 2001 15 7 1218 1220 2-s2.0-0035344017
184. Góra-Kupilas K., Jośko J., The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathologica 2005 43 1 31 39 2-s2.0-17344367099 (Pubitemid 40533190)
185. Volm M., Mattern J., Koomägi R., Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Research 1999 19 3A 1669 1671 2-s2.0-0032782809 (Pubitemid 29392721)
186. Cao G., Luo Y., Nagayama T., Pei W., Stetler R. A., Graham S. H., Chen J., Cloning and characterization ot rat caspase-9: implications for a role in mediating caspase-3 activation and hippocampal cell death after transient cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2002 22 5 534 546 2-s2.0-0036012750 (Pubitemid 34477775)
187. Graham S. H., Chen J., Programmed cell death in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2001 21 2 99 109 2-s2.0-0035122040 (Pubitemid 32143971)
188. Motterlini R., Foresti R., Bassi R., Calabrese V., Clark J. E., Green C. J., Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. Journal of Biological Chemistry 2000 275 18 13613 13620 2-s2.0-0034607632 10.1074/jbc.275.18.13613 (Pubitemid 30257429)
189. Nishie A., Ono M., Shono T., Fukushi J., Otsubo M., Onoue H., Ito Y., Inamura T., Ikezaki K., Fukui M., Iwaki T., Kuwano M., Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clinical Cancer Research 1999 5 5 1107 1113 2-s2.0-0032926784 (Pubitemid 29233226)
190. Ryter S. W., Si M., Lai C.-C., Su C.-Y., Regulation of endothelial heme oxygenase activity during hypoxia is dependent on chelatable iron. American Journal of Physiology-Heart and Circulatory Physiology 2000 279 6 H2889 H2897 2-s2.0-0034533986 (Pubitemid 32005879)
191. Dantz D., Bewersdorf J., Fruehwald-Schultes B., Kern W., Jelkmann W., Born J., Fehm H. L., Peters A., Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. Journal of Clinical Endocrinology and Metabolism 2002 87 2 835 840 2-s2.0-0036173406 10.1210/jc.87.2.835 (Pubitemid 34158260)
192. Bearden S. E., Segal S. S., Microvessels promote motor nerve survival and regeneration through local VEGF release following ectopic reattachment. Microcirculation 2004 11 8 633 644 2-s2.0-10944254866 10.1080/10739680490517659 (Pubitemid 40012342)
193. Foehring D., Brand-Saberi B., Theiss C., VEGF-induced growth cone enhancement is diminished by inhibiting tyrosine-residue 1214 of VEGFR-2. Cells Tissues Organs 2012 196 195 205 2-s2.0-84858320004 10.1159/000334600
194. Forstreuter F., Lucius R., Mentlein R., Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. Journal of Neuroimmunology 2002 132 1-2 93 98 2-s2.0-0036849437 10.1016/S0165-5728(02) 00315-6 (Pubitemid 35333330)
195. Herrán E., Pérez-González R., Igartua M., Pedraz J., Carro E., Hernández R., VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease. Journal of Controlled Release 2013 170 1 111 119 10.1016/j.jconrel.2013.04.028
196. Mani N., Khaibullina A., Krum J. M., Rosenstein J. M., Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Experimental Neurology 2005 192 2 394 406 2-s2.0-14844296510 10.1016/j.expneurol.2004.12.022 (Pubitemid 40341684)
197. Skene J. H. P., Cleveland D. W., Hypoxia and lou gehrig. Nature Genetics 2001 28 2 107 108 2-s2.0-0034967781 10.1038/88805 (Pubitemid 32538049)
198. Keifer O. P. Jr., O'Connor D. M., Boulis N. M., Gene and protein therapies utilizing VEGF for ALS. Pharmacology & Therapeutics 2014 141 3 261 271 10.1016/j.pharmthera.2013.10.009
199. Turner B. J., Talbot K., Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Progress in Neurobiology 2008 85 1 94 134 2-s2.0-42249102078 10.1016/j.pneurobio.2008.01.001
200. Lu L., Zheng L., Viera L., Suswam E., Li Y., Li X., Estévez A. G., King P. H., Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. Journal of Neuroscience 2007 27 30 7929 7938 2-s2.0-34547476995 10.1523/JNEUROSCI.1877-07.2007 (Pubitemid 47173324)
201. Li X., Lee C., Tang Z., Zhang F., Arjunan P., Li Y., Hou X., Kumar A., Dong L., VEGF-B: a survival, or an angiogenic factor? Cell Adhesion and Migration 2009 3 4 322 327 2-s2.0-70350445902
202. Lu L., Wang S., Zheng L., Li X., Suswam E. A., Zhang X., Wheeler C. G., Nabors L. B., Filippova N., King P. H., Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR). Implications for impaired post-transcriptional regulation of vascular endothelial growth factor. Journal of Biological Chemistry 2009 284 49 33989 33998 2-s2.0-71749088420 10.1074/jbc.M109.067918
203. Van Den Bosch L., Storkebaum E., Vleminckx V., Moons L., Vanopdenbosch L., Scheveneels W., Carmeliet P., Robberecht W., Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration. Neurobiology of Disease 2004 17 1 21 28 2-s2.0-4444377607 10.1016/j.nbd.2004.06.004 (Pubitemid 39209309)
204. Murakami T., Ilieva H., Shiote M., Nagata T., Nagano I., Shoji M., Abe K., Hypoxic induction of vascular endothelial growth factor is selectively impaired in mice carrying the mutant SOD1 gene. Brain Research 2003 989 2 231 237 2-s2.0-0141861939 10.1016/S0006-8993(03)03374-2 (Pubitemid 37211427)
205. Lladó J., Tolosa L., Olmos G., Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons. Frontiers in Cellular Neuroscience 2013 7 article 181
206. Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O'Banion M. K., Stojanovic K., Sagare A., Boillee S., Cleveland D. W., Zlokovic B. V., ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nature Neuroscience 2008 11 4 420 422 2-s2.0-41149097086 10.1038/nn2073 (Pubitemid 351441888)
207. Tolosa L., Mir M., Asensio V. J., Olmos G., Lladó J., Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase. Journal of Neurochemistry 2008 105 4 1080 1090 2-s2.0-42549127816 10.1111/j.1471-4159.2007. 05206.x (Pubitemid 351590778)
208. Tovar-y-Romo L. B., Tapia R., VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo by activation of PI3-K pathway and inhibition of p38MAPK. Journal of Neurochemistry 2010 115 5 1090 1101 2-s2.0-78149277977 10.1111/j.1471-4159.2010.06766.x
209. Ogunshola O. O., Antic A., Donoghue M. J., Fan S.-Y., Kim H., Stewart W. B., Madri J. A., Ment L. R., Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. Journal of Biological Chemistry 2002 277 13 11410 11415 2-s2.0-0037192788 10.1074/jbc.M111085200 (Pubitemid 34952908)
210. Brockington A., Wharton S. B., Fernando M., Gelsthorpe C. H., Baxter L., Ince P. G., Lewis C. E., Shaw P. J., Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology 2006 65 1 26 36 2-s2.0-33644913172 10.1097/01.jnen.0000196134.51217.74
211. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.-P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E. M., Collen D., Moons L., Carmeliet P., Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature Neuroscience 2005 8 1 85 92 2-s2.0-16644382257 10.1038/nn1360 (Pubitemid 41236736)
212. 165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in Vivo and in Vitro. The American Journal of Pathology 2013 183 3 918 929
213. Lemmens R., Van Hoecke A., Hersmus N., Geelen V., D'Hollander I., Thijs V., Van Den Bosch L., Carmeliet P., Robberecht W., Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Human Molecular Genetics 2007 16 19 2359 2365 2-s2.0-34548740744 10.1093/hmg/ddm193 (Pubitemid 47423902)
214. Da Costa M. M., Allen C. E., Higginbottom A., Ramesh T., Shaw P. J., McDermott C. J., A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Disease Models & Mechanisms 2014 7 1 73 81 10.1242/dmm.012013
215. Li B., Xu W., Luo C., Gozal D., Liu R., VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Molecular Brain Research 2003 111 1-2 155 164 2-s2.0-0037451069 10.1016/S0169-328X(03)00025-1 (Pubitemid 36332339)
216. Li X., VEGF-B: a thing of beauty. Cell Research 2010 20 7 741 744 2-s2.0-77955713744 10.1038/cr.2010.77
217. Li Y., Zhang F., Nagai N., Tang Z., Zhang S., Scotney P., Lennartsson J., Zhu C., Qu Y., Fang C., Hua J., Matsuo O., Fong G.-H., Ding H., Cao Y., Becker K. G., Nash A., Heldin C.-H., Li X., VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. Journal of Clinical Investigation 2008 118 3 913 923 2-s2.0-40549090548 10.1172/JCI33673 (Pubitemid 351364599)
218. Zhang F., Tang Z., Hou X., Lennartsson J., Li Y., Koch A. W., Scotney P., Lee C., Arjunan P., Dong L., Kumar A., Rissanen T. T., Wang B., Nagai N., Fons P., Fariss R., Zhang Y., Wawrousek E., Tansey G., Raber J., Fong G.-H., Ding H., Greenberg D. A., Becker K. G., Herbert J.-M., Nash A., Yla-Herttuala S., Cao Y., Watts R. J., Lia X., VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 15 6152 6157 2-s2.0-65549139264 10.1073/pnas. 0813061106
219. Li X., Kumar A., Zhang F., Lee C., Tang Z., Complicated life, complicated VEGF-B. Trends in Molecular Medicine 2012 18 2 119 127 2-s2.0-84856684201 10.1016/j.molmed.2011.11.006
220. Poesen K., Lambrechts D., Van Damme P., Dhondt J., Bender F., Frank N., Bogaert E., Claes B., Heylen L., Verheyen A., Raes K., Tjwa M., Eriksson U., Shibuya M., Nuydens R., Van Den Bosch L., Meert T., D'Hooge R., Sendtner M., Robberecht W., Carmeliet P., Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration. Journal of Neuroscience 2008 28 42 10451 10459 2-s2.0-54849424014 10.1523/JNEUROSCI.1092- 08.2008
221. Harrigan M. R., Ennis S. R., Sullivan S. E., Keep R. F., Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochirurgica 2003 145 1 49 53 2-s2.0-0037266459 10.1007/s00701-002-1035-1 (Pubitemid 36174080)
222. Xie L., Mao X., Jin K., Greenberg D. A., Vascular endothelial growth factor-B expression in postischemic rat brain. Vascular Cell 2013 5 1 1 5
223. Koppers M., van Es M., van den Berg L. H., Veldink J. H., Pasterkamp R. J., Genetics of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 2012 New York, NY, USA InTech 479 516
224. Brockington A., Kirby J., Eggitt D., Schofield E., Morris C., Lewis C. E., Ince P. G., Shaw P. J., Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics 2005 6 2 101 104 2-s2.0-20044384733 10.1007/s10048-004-0201-4 (Pubitemid 40768122)
225. Gros-Louis F., Laurent S., Lopes A. A. S., Khoris J., Meminger V., Camu W., Rouleau G. A., Absence of mutations in the hypoxia response element of VEGF in ALS. Muscle and Nerve 2003 28 6 774 775 2-s2.0-0344012211 10.1002/mus.10498 (Pubitemid 37484845)
226. Lambrechts D., Poesen K., Fernández-Santiago R., Al-Chalabi A., Del Bo R., Van Vught P. W. J., Khan S., Marklund S. L., Brockington A., Van Marion I., Anneser J., Shaw C., Ludolph A. C., Leigh N. P., Comi G. P., Gasser T., Shaw P. J., Morrison K. E., Andersen P. M., Van Den Berg L. H., Thijs V., Siddique T., Robberecht W., Carmeliet P., Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. Journal of Medical Genetics 2009 46 12 840 846 2-s2.0-72749106555 10.1136/jmg.2008.058222
227. Terry P. D., Kamel F., Umbach D. M., Lehman T. A., Hu H., Sandler D. P., Taylor J. A., VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS). Journal of Neurogenetics 2004 18 2 429 434 2-s2.0-11144239636 10.1080/01677060490894450 (Pubitemid 40052752)
228. Avakian G. N., Nikonov A. A., Katunina E. A., Avakian V. N., Nikonova A. A., Gusev E. I., Differential diagnostic criteria of lateral amyotrophic sclerosis. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova / Ministerstvo Zdravookhraneniia i Meditsinskoi Promyshlennosti Rossiiskoi Federatsii, Vserossiiskoe Obshchestvo Nevrologov [i] Vserossiiskoe Obshchestvo Psikhiatrov 2002 102 1 22 25 2-s2.0-0036372211
229. Zhang Y., Zhang H., Fu Y., Song H., Wang L., Zhang J., Fan D., VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients. Amyotrophic Lateral Sclerosis 2006 7 2 119 122 2-s2.0-33745063938 10.1080/14660820600600657 (Pubitemid 43878834)
230. Del Bo R., Scarlato M., Ghezzi S., Martinelli-Boneschi F., Corti S., Locatelli F., Santoro D., Prelle A., Briani C., Nardini M., Siciliano G., Mancuso M., Murri L., Bresolin N., Comi G. P., Absence of angiogenic genes modification in Italian ALS patients. Neurobiology of Aging 2008 29 2 314 316 2-s2.0-37549038185 10.1016/j.neurobiolaging.2006.10.008
231. Van Vught P. W. J., Sutedja N. A., Veldink J. H., Koeleman B. P. C., Groeneveld G. J., Wijmenga C., Uitdehaag B. M. J., De Jong J. M. B. V., Baas F., Wokke J. H. J., Van Den Berg L. H., Lack of association between VEGF polymorphisms and ALS in a Dutch population. Neurology 2005 65 10 1643 1645 2-s2.0-28044435808 10.1212/01.wnl.0000184514.39853.56 (Pubitemid 41689483)
232. Fernández-Santiago R., Sharma M., Mueller J. C., Gohlke H., Illig T., Anneser J., Münch C., Ludolph A., Kamm C., Gasser T., Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS. Neurology 2006 66 12 1929 1931 2-s2.0-33745890898 10.1212/01.wnl. 0000219756.71928.25 (Pubitemid 44049831)
233. Chen W., Saeed M., Mao H., Siddique N., Dellefave L., Hung W.-Y., Deng H.-X., Sufit R. L., Heller S. L., Haines J. L., Pericak-Vance M., Siddique T., Lack of association of VEGF promoter polymorphisms with sporadic ALS. Neurology 2006 67 3 508 510 2-s2.0-33747037794 10.1212/01.wnl.0000227926.42370.04 (Pubitemid 44214985)
234. Hormbrey E., Gillespie P., Turner K., Han C., Roberts A., McGrouther D., Harris A. L., A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clinical and Experimental Metastasis 2002 19 8 651 663 2-s2.0-0036940022 10.1023/A:1021379811308 (Pubitemid 36092260)
235. Nobile-Orazio E., Terenghi F., Giannotta C., Gallia F., Nozza A., Serum vegf levels in poems syndrome and in immune-mediated neuropathies. Neurology 2009 72 11 1024 1026 2-s2.0-64049113959 10.1212/01.wnl.0000344569.13496.ff
236. Nygren I., Larsson A., Johansson A., Askmark H., VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis. NeuroReport 2002 13 17 2199 2201 2-s2.0-0037016172 10.1097/00001756-200212030- 00007 (Pubitemid 36044428)
237. Just N., Moreau C., Lassalle P., Gosset P., Perez T., Brunaud-Danel V., Wallaert B., Destée A., Defebvre L., Tonnel A. B., Devos D., High erythropoietin and low vascular endothelial growth factor levels in cerebrospinal fluid from hypoxemic ALS patients suggest an abnormal response to hypoxia. Neuromuscular Disorders 2007 17 2 169 173 2-s2.0-33847215121 10.1016/j.nmd.2006.10.004
238. Devos D., Moreau C., Lassalle P., Perez T., De Seze J., Brunaud-Danel V., Destée A., Tonnel A. B., Just N., Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 2004 62 11 2127 2129 2-s2.0-2942627907 (Pubitemid 38738240)
239. Moreau C., Devos D., Brunaud-Danel V., Defebvre L., Perez T., Destée A., Tonnel A. B., Lassalle P., Just N., Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS. Journal of Neurology,
240. Carilho R., de Carvalho M., Swash M., Pinto S., Pinto A., Costa J., Vascular endothelial growth factor and amyotrophic lateral sclerosis: the Interplay with exercise and non-invasive ventilation. Muscle & Nerve 2013 49 545 550
241. Moreau C., Gosset P., Kluza J., Brunaud-Danel V., Lassalle P., Marchetti P., Defebvre L., Destée A., Devos D., Deregulation of the hypoxia inducible factor-1 α pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience 2011 172 110 117 2-s2.0-78650721472 10.1016/j.neuroscience.2010.10.040
242. Gupta P. K., Prabhakar S., Sharma S., Anand A., Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 2011 8, article 97 2-s2.0-80051534543 10.1186/1742-2094-8-97
243. Ilzecka J., Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery 2004 106 4 289 293 2-s2.0-3543056930 10.1016/j.clineuro.2003.12.007 (Pubitemid 39024628)
244. Moreau C., Gosset P., Brunaud-Danel V., Lassalle P., Degonne B., Destee A., Defebvre L., Devos D., CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients. Amyotrophic Lateral Sclerosis 2009 10 3 175 181 2-s2.0-67651148186 10.1080/17482960802651725
245. Breen E. C., Johnson E. C., Wagner H., Tseng H.-M., Sung L. A., Wagner P. D., Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. Journal of Applied Physiology 1996 81 1 355 361 2-s2.0-0030017356 (Pubitemid 26255530)
246. Sathasivam S., VEGF and ALS. Neuroscience Research 2008 62 2 71 77 2-s2.0-50449086167 10.1016/j.neures.2008.06.008
247. Azimi-Nezhad M., Lambert D., Ottone C., Perrin C., Chapel C., Gaillard G., Pfister M., Masson C., Tabone E., Betsou F., Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations. Biopreservation and Biobanking 2012 10 5 454 461
248. Hetland M. L., Christensen I. J., Lottenburger T., Johansen J. S., Svendsen M. N., Hørslev-Petersen K., Nielsen L., Jørgen Nielsen H., Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Preanalytical and biological variability in healthy persons and in patients. Disease Markers 2008 24 1 1 10 2-s2.0-36448967835 (Pubitemid 350174565)
249. Brockington A., Wokke B., Nixon H., Hartley J. A., Shaw P. J., Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis. BMC Medical Genetics 2007 8, article 23 2-s2.0-34248569426 10.1186/1471-2350-8-23 (Pubitemid 46785009)
250. Dewil M., Lambrechts D., Sciot R., Shaw P. J., Ince P. G., Robberecht W., Van Den Bosch L., Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology 2007 33 5 499 509 2-s2.0-34548552816 10.1111/j.1365-2990.2007.00850.x (Pubitemid 47390084)
251. Bogaert E., Van Damme P., Poesen K., Dhondt J., Hersmus N., Kiraly D., Scheveneels W., Robberecht W., Van Den Bosch L., VEGF protects motor neurons against excitotoxicity by upregulation of GluR2. Neurobiology of Aging 2010 31 12 2185 2191 2-s2.0-77953732352 10.1016/j.neurobiolaging.2008.12.007
252. Van Damme P., Bogaert E., Dewil M., Hersmus N., Kiraly D., Scheveneels W., Bockx I., Braeken D., Verpoorten N., Verhoeven K., Timmerman V., Herijgers P., Callewaert G., Carmeliet P., Van Bosch L. D., Robberecht W., Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proceedings of the National Academy of Sciences of the United States of America 2007 104 37 14825 14830 2-s2.0-35548983991 10.1073/pnas.0705046104 (Pubitemid 350003227)
253. Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., Robberecht W., GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. Journal of Neurophysiology 2002 88 3 1279 1287 2-s2.0-0036713846 (Pubitemid 35025382)
254. Zheng C., Nennesmo I., Fadeel B., Henter J.-I., Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Annals of Neurology 2004 56 4 564 567 2-s2.0-4844227301 10.1002/ana.20223 (Pubitemid 39319348)
255. Yang J.-P., Liu H.-J., Cheng S.-M., Wang Z.-L., Cheng X., Yu H.-X., Liu X.-F., Direct transport of VEGF from the nasal cavity to brain. Neuroscience Letters 2009 449 2 108 111 2-s2.0-56949099547 10.1016/j.neulet.2008.10.090
256. Dodge J. C., Treleaven C. M., Fidler J. A., Hester M., Haidet A., Handy C., Rao M., Eagle A., Matthews J. C., Taksir T. V., Cheng S. H., Shihabuddin L. S., Kaspar B. K., AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice. Molecular Therapy 2010 18 12 2075 2084 2-s2.0-78650918245 10.1038/mt.2010.206
257. Sakowski S. A., Heavener S. B., Lunn J. S., Fung K., Oh S. S., Spratt S. K., Hogikyan N. D., Feldman E. L., Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression. Gene Therapy 2009 16 11 1292 1299 2-s2.0-70449722852 10.1038/gt.2009.111
258. Kliem M. A., Heeke B. L., Franz C. K., Radovitskiy I., Raore B., Barrow E., Snyder B. R., Federici T., Kaye Spratt S., Boulis N. M., Intramuscular administration of a VEGF zinc finger transcription factor activator (VEGF-ZFP-TF) improves functional outcomes in SOD1 rats. Amyotrophic Lateral Sclerosis 2011 12 5 331 339 2-s2.0-80053972328 10.3109/17482968.2011.574142
259. Shiote M., Nagano I., Ilieva H., Murakami T., Narai H., Ohta Y., Nagata T., Shoji M., Abe K., Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia. Neuroscience 2005 132 1 175 182 2-s2.0-15044350330 10.1016/j.neuroscience.2004.12.031 (Pubitemid 40380724)
260. Teng Y. D., Benn S. C., Kalkanis S. N., Shefner J. M., Onario R. C., Cheng B., Lachyankar M. B., Marconi M., Li J., Yu D., Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Science Translational Medicine 2012 4 165 165ra164
261. Ferraiuolo L., Frakes A., Kaspar B. K., Neural stem cells as a therapeutic approach for amyotrophic lateral sclerosis. Molecular Therapy 2013 21 3 503 505
262. Hwang D. H., Lee H. J., Park I. H., Seok J. I., Kim B. G., Joo I. S., Kim S. U., Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Therapy 2009 16 10 1234 1244 2-s2.0-70350167840 10.1038/gt.2009.80
263. Zhang C., Zhou C., Teng J.-J., Zhao R.-L., Song Y.-Q., Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis. Cytotherapy 2009 11 3 299 306 2-s2.0-68049116659 10.1080/14653240902806986
264. Krakora D., Mulcrone P., Meyer M., Lewis C., Bernau K., Gowing G., Zimprich C., Aebischer P., Svendsen C. N., Suzuki M., Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Molecular Therapy 2013 21 8 1602 1610 10.1038/mt.2013.108
265. Gu R., Hou X., Pang R., Li L., Chen F., Geng J., Xu Y., Zhang C., Human adipose-derived stem cells enhance the glutamate uptake function of GLT1 in SOD1G93A-bearing astrocytes. Biochemical and Biophysical Research Communications 2010 393 3 481 486 2-s2.0-77949273896 10.1016/j.bbrc.2010.02.029
266. Constantin G., Marconi S., Rossi B., Angiari S., Calderan L., Anghileri E., Gini B., Bach S. D., Martinello M., Bifari F., Galiè M., Turano E., Budui S., Sbarbati A., Krampera M., Bonetti B., Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 2009 27 10 2624 2635 2-s2.0-70350212973 10.1002/stem.194
267. Marconi S., Castiglione G., Turano E., Bissolotti G., Angiari S., Farinazzo A., Constantin G., Bedogni G., Bedogni A., Bonetti B., Human adipose-derived mesenchymal stem cells systemically injected promote peripheral nerve regeneration in the mouse model of sciatic crush. Tissue Engineering Part A 2012 18 11-12 1264 1272
268. Marconi S., Bonaconsa M., Scambi I., Squintani G. M., Rui W., Turano E., Ungaro D., D'Agostino S., Barbieri F., Angiari S., Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience 2013 248C 333 343 10.1016/j.neuroscience.2013.05.034
269. Corti S., Nizzardo M., Nardini M., Donadoni C., Salani S., Simone C., Falcone M., Riboldi G., Govoni A., Bresolin N., Comi G. P., Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Human Molecular Genetics 2010 19 19 3782 3796 2-s2.0-77956524950 10.1093/hmg/ddq293
270. Pandya R. S., Mao L. L. J., Zhou E. W., Bowser R., Zhu Z., Zhu Y., Wang X., Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy. Central Nervous System Agents in Medicinal Chemistry 2012 12 1 15 27 2-s2.0-84860505100
271. Rizvanov A. A., Kiyasov A. P., Gaziziov I. M., Yilmaz T. S., Kaligin M. S., Andreeva D. I., Shafigullina A. K., Guseva D. S., Kiselev S. L., Matin K., Palotás A., Islamov R. R., Human umbilical cord blood cells transfected with VEGF and L1CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochemistry International 2008 53 6-8 389 394 2-s2.0-56649118944 10.1016/j.neuint.2008.09. 011
272. Proescholdt M. A., Heiss J. D., Walbridge S., Mühlhauser J., Capogrossi M. C., Oldfield E. H., Merrill M. J., Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. Journal of Neuropathology and Experimental Neurology 1999 58 6 613 627 2-s2.0-0032991449 (Pubitemid 29264941)
273. Dobrogowska D. H., Lossinsky A. S., Tarnawski M., Vorbrodt A. W., Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. Journal of Neurocytology 1998 27 3 163 173 2-s2.0-0031779653 10.1023/A:1006907608230 (Pubitemid 28253067)
274. De Carvalho M., Scotto M., Lopes A., Swash M., Quantitating progression in ALS. Neurology 2005 64 10 1783 1785 2-s2.0-18844370172 10.1212/01.WNL. 0000162036.76024.AB (Pubitemid 40695819)
275. Ropper A. H., Gorson K. C., Gooch C. L., Weinberg D. H., Pieczek A., Ware J. H., Kershen J., Rogers A., Simovic D., Schratzberger P., Kirchmair R., Losordo D., Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Annals of Neurology 2009 65 4 386 393 2-s2.0-65649114702 10.1002/ana.21675
276. Wang Z.-G., Puri T. S., Quigg R. J., Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse. Biochemical Journal 2010 428 3 347 354 2-s2.0-77954911005 10.1042/BJ20100379
277. Schänzer A., Wachs F.-P., Wilhelm D., Acker T., Cooper-Kuhn C., Beck H., Winkler J., Aigner L., Plate K. H., Kuhn G., Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathology 2004 14 3 237 248 2-s2.0-4143127545 (Pubitemid 39095985)
278. Hashimoto T., Zhang X.-M., Chen B. Y.-K., Yang X.-J., VEGF activates divergent intracellular signaling components to regulate retinal progenitor cell proliferation and neuronal differentiation. Development 2006 133 11 2201 2210 2-s2.0-33745617089 10.1242/dev.02385 (Pubitemid 43986130)
279. Schwartz C. M., Tavakoli T., Jamias C., Park S.-S., Maudsley S., Martin B., Phillips T. M., Yao P. J., Itoh K., Ma W., Rao M. S., Arenas E., Mattson M. P., Stromal factors SDF1 α sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells. Journal of Neuroscience Research 2012 90 7 1367 1381 2-s2.0-84860195400 10.1002/jnr.23064
280. Erskine L., Reijntjes S., Pratt T., Denti L., Schwarz Q., Vieira J. M., Alakakone B., Shewan D., Ruhrberg C., VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm. Neuron 2011 70 5 951 965 2-s2.0-79958044393 10.1016/j.neuron.2011.02.052
281. Ruiz de Almodovar C., Fabre P. J., Knevels E., Coulon C., Segura I., Haddick P. C. G., Aerts L., Delattin N., Strasser G., Oh W.-J., Lange C., Vinckier S., Haigh J., Fouquet C., Gu C., Alitalo K., Castellani V., Tessier-Lavigne M., Chedotal A., Charron F., Carmeliet P., VEGF mediates commissural axon chemoattraction through its receptor Flk1. Neuron 2011 70 5 966 978 2-s2.0-79958036737 10.1016/j.neuron.2011.04.014
282. Rosenstein J. M., Mani N., Khaibullina A., Krum J. M., Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. Journal of Neuroscience 2003 23 35 11036 11044 2-s2.0-0346118855 (Pubitemid 37548937)
283. Svensson B., Peters M., König H.-G., Poppe M., Levkau B., Rothermundt M., Arolt V., Kögel D., Prehn J. H. M., Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. Journal of Cerebral Blood Flow and Metabolism 2002 22 10 1170 1175 2-s2.0-0036790806
284. Ma Y., Liu W., Wang Y., Chao X., Qu Y., Wang K., Fei Z., VEGF protects rat cortical neurons from mechanical trauma injury induced apoptosis via the MEK/ERK pathway. Brain Research Bulletin 2011 86 5-6 441 446 2-s2.0-82755193685 10.1016/j.brainresbull.2011.07.007
285. Shin Y.-J., Choi J.-S., Lee J.-Y., Choi J.-Y., Cha J.-H., Chun M.-H., Lee M.-Y., Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathologica 2008 116 5 517 527 2-s2.0-54149116064 10.1007/s00401-008-0423-x
286. Kranich S., Hattermann K., Specht A., Lucius R., Mentlein R., VEGFR-3/Flt-4 mediates proliferation and chemotaxis in glial precursor cells. Neurochemistry International 2009 55 8 747 753 2-s2.0-70349970737 10.1016/j.neuint.2009.07.007
287. Mauceri D., Freitag H. E., Oliveira A. M. M., Bengtson C. P., Bading H., Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation. Neuron 2011 71 1 117 130 2-s2.0-79960179301 10.1016/j.neuron.2011.04.022
288. Beck H., Acker T., Püschel A. W., Fujisawa H., Carmeliet P., Plate K. H., Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling. Journal of Neuropathology and Experimental Neurology 2002 61 4 339 350 2-s2.0-0036202011 (Pubitemid 34266785)
289. Du H., Li P., Pan Y., Li W., Hou J., Chen H., Wang J., Tang H., Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model. Brain Research 2010 1357 1 8 2-s2.0-77957260354 10.1016/j.brainres.2010.07.015
290. Kim B. W., Choi M., Kim Y.-S., Park H., Lee H.-R., Yun C.-O., Kim E. J., Choi J.-S., Kim S., Rhim H., Kaang B.-K., Son H., Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. Cellular Signalling 2008 20 4 714 725 2-s2.0-39149118884 10.1016/j.cellsig.2007.12.009
291. Licht T., Eavri R., Goshen I., Shlomai Y., Mizrahi A., Keshet E., VEGF is required for dendritogenesis of newly born olfactory bulb interneurons. Development 2010 137 2 261 271 2-s2.0-73649124594 10.1242/dev.039636
292. Licht T., Goshen I., Avital A., Kreisel T., Zubedat S., Eavri R., Segal M., Yirmiya R., Keshet E., Reversible modulations of neuronal plasticity by VEGF. Proceedings of the National Academy of Sciences of the United States of America 2011 108 12 5081 5086 2-s2.0-79953170934 10.1073/pnas.1007640108
293. Licht T., Keshet E., Delineating multiple functions of VEGF-A in the adult brain. Cellular and Molecular Life Sciences 2013 70 10 1727 1737 10.1007/s00018-013-1280-x
294. Proia P., Schiera G., Mineo M., Ingrassia A. M. R., Santoro G., Savettieri G., Di Liegro I., Astrocytes shed extracellular vesicles that contain fibroblast growth factor-2 and vascular endothelial growth factor. International Journal of Molecular Medicine 2008 21 1 63 67 2-s2.0-38949152658 (Pubitemid 351222869)
295. Schiera G., Proia P., Alberti C., Mineo M., Savettieri G., Di Liegro I., Neurons produce FGF2 and VEGF and secrete them at least in part by shedding extracellular vesicles. Journal of Cellular and Molecular Medicine 2007 11 6 1384 1394 2-s2.0-38149108464 10.1111/j.1582-4934.2007.00100.x
296. Sondell M., Sundler F., Kanje M., Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. European Journal of Neuroscience 2000 12 12 4243 4254 2-s2.0-0034502527 10.1046/j.0953-816X.2000.01326.x (Pubitemid 32037835)
297. Bellon A., Luchino J., Haigh K., Rougon G., Haigh J., Chauvet S., Mann F., VEGFR2 (KDR/Flk1) signaling mediates axon growth in response to semaphorin 3E in the developing brain. Neuron 2010 66 2 205 219 2-s2.0-77952386743 10.1016/j.neuron.2010.04.006
298. Pitzer M. R., Sortwell C. E., Daley B. F., McGuire S. O., Marchionini D., Fleming M., Collier T. J., Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells. Experimental Neurology 2003 182 2 435 445 2-s2.0-0042665632 10.1016/S0014-4886(03)00100-6 (Pubitemid 36937096)